Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
0.6315
+0.0391 (6.60%)
At close: May 29, 2025, 4:00 PM
0.6423
+0.0108 (1.71%)
After-hours: May 29, 2025, 7:42 PM EDT

Ironwood Pharmaceuticals Stock Forecast

IRWD's stock price has decreased by -89.26% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 5 professional analysts, the 12-month price target for Ironwood Pharmaceuticals stock ranges from a low of $0.70 to a high of $14. The average analyst price target of $4.94 forecasts a 682.26% increase in the stock price over the next year.

Price Target: $4.94 (+682.26%)
Analyst Consensus: Buy
Target Low Average Median High
Price $0.70 $4.94 $1.00 $14
Change +10.85% +682.26% +58.35% +2116.9%
* Price targets were last updated on Apr 15, 2025.

Analyst Ratings

The average analyst rating for Ironwood Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 111111
Buy 333311
Hold 111133
Sell 000000
Strong Sell 000000
Total 555555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wells Fargo
Wells Fargo
Hold
Downgrades
$7$1
Hold Downgrades $7$1 +58.35% Apr 15, 2025
Jefferies
Jefferies
Hold
Downgrades
$8$0.7
Hold Downgrades $8$0.7 +10.85% Apr 15, 2025
Leerink Partners
Leerink Partners
Hold
Maintains
$3$1
Hold Maintains $3$1 +58.35% Apr 14, 2025
JMP Securities
JMP Securities
Buy
Maintains
$23$14
Buy Maintains $23$14 +2,116.94% Jan 30, 2025
Craig-Hallum
Craig-Hallum
Strong Buy
Maintains
$10$8
Strong Buy Maintains $10$8 +1,166.83% Jan 22, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
276.01M
from 351.41M
Decreased by -21.46%
Revenue Next Year
253.44M
from 276.01M
Decreased by -8.18%
EPS This Year
0.19
from 0.01
Increased by 3,403.89%
EPS Next Year
0.28
from 0.19
Increased by 42.11%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
389.52M413.75M410.60M442.74M351.41M276.01M253.44M183.60M
Revenue Growth
-9.08%6.22%-0.76%7.83%-20.63%-21.46%-8.18%-27.56%
EPS
0.663.210.96-6.450.010.190.28-0.10
EPS Growth
378.84%386.36%-69.98%--3,403.89%42.11%-
Forward PE
-----3.262.29-
No. Analysts
-----885
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 288.2M 288.3M 189.0M
Avg 276.0M 253.4M 183.6M
Low 258.8M 221.5M 176.4M

Revenue Growth

Revenue Growth 20252026202720282029
High
-18.0%
4.5%
-25.4%
Avg
-21.5%
-8.2%
-27.6%
Low
-26.3%
-19.8%
-30.4%

EPS Forecast

EPS 20252026202720282029
High 0.23 0.33 -0.11
Avg 0.19 0.28 -0.10
Low 0.16 0.23 -0.10

EPS Growth

EPS Growth 20252026202720282029
High
4,076.5%
68.0%
-
Avg
3,403.9%
42.1%
-
Low
2,734.9%
16.3%
-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.